AKR1C2
Basic information
Region (hg38): 10:4987775-5018031
Previous symbols: [ "DDH2", "TDD" ]
Links
Phenotypes
GenCC
Source:
- 46,XY disorder of sex development due to testicular 17,20-desmolase deficiency (Supportive), mode of inheritance: AR
- 46,XY disorder of sex development due to testicular 17,20-desmolase deficiency (Limited), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
46,XY sex reversal 8 | AR | Genitourinary; Oncologic | Surveillance and/or awareness of cancer risk, and preventive measures may be beneficial to reduce the risk of gonadal tumors | Endocrine; Genitourinary; Oncologic | 4352099; 21802064 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the AKR1C2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 9 | |||||
missense | 18 | 21 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 1 | 1 | ||||
non coding | 45 | 46 | ||||
Total | 0 | 0 | 21 | 9 | 49 |
Variants in AKR1C2
This is a list of pathogenic ClinVar variants found in the AKR1C2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-4989685-C-T | Benign (Jul 09, 2018) | |||
10-4989699-G-T | Benign (Feb 04, 2019) | |||
10-4989823-C-T | Benign (Jul 09, 2018) | |||
10-4990047-A-AG | Benign (Jul 05, 2018) | |||
10-4990092-C-T | Benign (Jul 09, 2018) | |||
10-4990094-C-G | Benign (Jul 09, 2018) | |||
10-4990242-C-A | Benign (Jul 09, 2018) | |||
10-4991645-C-A | Benign (Jul 09, 2018) | |||
10-4991646-A-G | Benign (Jul 09, 2018) | |||
10-4991824-T-C | Benign (Jul 09, 2018) | |||
10-4991861-T-G | 46,XY disorder of sex development due to testicular 17,20-desmolase deficiency | Pathogenic (Aug 12, 2011) | ||
10-4991964-A-G | Benign (Jul 10, 2018) | |||
10-4992025-C-T | Benign (Jul 09, 2018) | |||
10-4992190-T-C | Benign (Feb 04, 2019) | |||
10-4995068-T-C | Benign (Oct 05, 2019) | |||
10-4995242-TC-T | Benign (Jul 09, 2018) | |||
10-4995336-TGC-T | 46,XY disorder of sex development due to testicular 17,20-desmolase deficiency | Uncertain significance (May 02, 2023) | ||
10-4995339-G-A | not specified | Uncertain significance (Sep 25, 2023) | ||
10-4995378-G-A | not specified | Uncertain significance (Feb 08, 2023) | ||
10-4995382-C-T | AKR1C2-related disorder | Likely benign (Apr 03, 2019) | ||
10-4995392-C-T | not specified | Uncertain significance (Dec 31, 2023) | ||
10-4995393-G-A | AKR1C2-related disorder | Benign (Nov 25, 2019) | ||
10-4995401-A-C | not specified | Uncertain significance (Dec 28, 2022) | ||
10-4995445-G-T | AKR1C2-related disorder | Likely benign (Aug 24, 2022) | ||
10-4995523-G-C | Benign (Jul 09, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
AKR1C2 | protein_coding | protein_coding | ENST00000380753 | 9 | 30257 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
6.90e-11 | 0.0709 | 125516 | 0 | 231 | 125747 | 0.000919 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.873 | 176 | 146 | 1.20 | 0.00000713 | 2083 |
Missense in Polyphen | 73 | 63.343 | 1.1524 | 904 | ||
Synonymous | -1.87 | 77 | 58.8 | 1.31 | 0.00000306 | 610 |
Loss of Function | 0.140 | 16 | 16.6 | 0.963 | 0.00000101 | 212 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00108 | 0.00107 |
Ashkenazi Jewish | 0.00605 | 0.00607 |
East Asian | 0.00252 | 0.00245 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000318 | 0.000316 |
Middle Eastern | 0.00252 | 0.00245 |
South Asian | 0.00180 | 0.00180 |
Other | 0.000979 | 0.000978 |
dbNSFP
Source:
- Function
- FUNCTION: Works in concert with the 5-alpha/5-beta-steroid reductases to convert steroid hormones into the 3-alpha/5-alpha and 3-alpha/5-beta-tetrahydrosteroids. Catalyzes the inactivation of the most potent androgen 5-alpha-dihydrotestosterone (5-alpha- DHT) to 5-alpha-androstane-3-alpha,17-beta-diol (3-alpha-diol). Has a high bile-binding ability. {ECO:0000269|PubMed:15929998, ECO:0000269|PubMed:17034817, ECO:0000269|PubMed:17442338, ECO:0000269|PubMed:8573067}.;
- Pathway
- Steroid hormone biosynthesis - Homo sapiens (human);Chemical carcinogenesis - Homo sapiens (human);Benzo(a)pyrene metabolism;Metapathway biotransformation Phase I and II;Prostaglandin Synthesis and Regulation;Metabolism of lipids;Metabolism;Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol;allopregnanolone biosynthesis;Synthesis of bile acids and bile salts via 24-hydroxycholesterol;Synthesis of bile acids and bile salts via 27-hydroxycholesterol;Synthesis of bile acids and bile salts;Bile acid and bile salt metabolism;Metabolism of steroids
(Consensus)
Intolerance Scores
- loftool
- 0.916
- rvis_EVS
- -0.09
- rvis_percentile_EVS
- 46.74
Haploinsufficiency Scores
- pHI
- 0.0666
- hipred
- N
- hipred_score
- 0.195
- ghis
- 0.502
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.908
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Akr1c21
- Phenotype
Gene ontology
- Biological process
- prostaglandin metabolic process;G protein-coupled receptor signaling pathway;digestion;steroid metabolic process;positive regulation of cell population proliferation;epithelial cell differentiation;progesterone metabolic process;daunorubicin metabolic process;doxorubicin metabolic process;positive regulation of protein kinase B signaling;oxidation-reduction process;cellular response to jasmonic acid stimulus;cellular response to prostaglandin D stimulus
- Cellular component
- cytoplasm;cytosol
- Molecular function
- alditol:NADP+ 1-oxidoreductase activity;alcohol dehydrogenase (NADP+) activity;steroid dehydrogenase activity;oxidoreductase activity;oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor;phenanthrene 9,10-monooxygenase activity;carboxylic acid binding;bile acid binding;ketosteroid monooxygenase activity;trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity